G. Berthod

Discipline

Economies et finances (1)

Type de document

Articles (9) Recensions (1) Colloques et conférences (1)

Co-auteur

Date

Source

Mot-clé

Patients (9) Patients (9) Treatment (7) Melanoma (6) Human beings (6) maladie (5) maladie (5) thérapie (4) survie (4) Case (4) Inhibitors (4) Therapeutics (4) Survival (4) Grammar, Comparative and general--Case (4) Case (4) Use (4) adulte (3) procès (3) abords (agglomération) (3) Diagnosis (3) Chemotherapy (3) Rates (3) Theater (3) Metastasis (3) Immunotherapy (3) Drama (3) Diagnosis (3) Chemotherapy (3) Acting (3) Rates (3)

Documents écrit par G. Berthod (10) | parle de G. Berthod (0)

ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study.
C. Bonnet et al. (1 juin 2023)
Estimated Costs of the Ipilimumab-Nivolumab Therapy and Related Adverse Events in Metastatic Melanoma.
B. Gautron Moura et al. (21 déc. 2022)
Safety and Efficacy of Ipilimumab plus Nivolumab and Sequential Selective Internal Radiation Therapy in Hepatic and Extrahepatic Metastatic Uveal Melanoma.
C.L. Gérard et al. (24 févr. 2022)
Mélanome localement avancé et métastatique : nouveautés [Locally advanced and metastatic melanoma : novelties]
A. Huber et al. (27 mai 2020)
Multiple nivolumab-induced CNS demyelination with spontaneous resolution in an asymptomatic metastatic melanoma patient.
V. Pillonel et al. (2 déc. 2019)
Sinonasal relapses of a primary isolated extranodal NK/T-cell lymphoma of the testis.
B. Hallak et al. (13 août 2019)
Vaccination with LAG-3Ig (IMP321) and peptides induces specific CD4 and CD8 T-cell responses in metastatic melanoma patients - report of a phase I/IIa clinical trial.
A. Legat et al. (2016)
Vaccination-induced functional competence of circulating human tumor-specific CD8 T-cells.
P. Baumgaertner et al. (2012)
Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07).
K. Zaman et al. (2012)
Prospective assessment of CYP2D6 by genotyping, phenotyping and measurement of tamoxifen, PD 05-09 4-hydroxy-tamoxifen and endoxifen in breast cancer patients treated with tamoxifen.
K. Zaman et al. (2010)